Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer

Overview of attention for article published in Acta Neurologica Belgica, January 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 9,614 followers.

#ANB Read for #FREE Top articles on #neurovascular diseases hand-picked by the EiC, P. Cras https://t.co/9wQ9NPmBHP https://t.co/FY8EcXJlBs https://t.co/71PPSUi8os #Recommendations #Stroke #Biomarkers #Imaging #Rehabilitation #rTMS #thrombolysis #Dabigat

Reply Repost Favourite

Intravenous #thrombolysis after reversal of #dabigatran by #idarucizumab: moment to be a pioneer #Stroke #Improvise https://t.co/Uwuq4Fb0KI

Reply Repost Favourite